-
1مورد إلكتروني
مصطلحات الفهرس: SLEDAI, social status, systemic lupus erythematosus/dt [Drug Therapy], autoantibody/ec [Endogenous Compound], azathioprine/dt [Drug Therapy], beta2 glycoprotein 1 antibody/ec [Endogenous Compound], cardiolipin antibody/ec [Endogenous Compound], corticosteroid/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], double stranded DNA antibody/ec [Endogenous Compound], hydroxychloroquine/dt [Drug Therapy], La antibody/ec [Endogenous Compound], leflunomide/dt [Drug Therapy], lupus anticoagulant/ec [Endogenous Compound], mercaptopurine/dt [Drug Therapy], methotrexate/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], neutrophil cytoplasmic antibody/ec [Endogenous Compound], phospholipid antibody/ec [Endogenous Compound], prednisolone/dt [Drug Therapy], rheumatoid factor/ec [Endogenous Compound], ribonucleoprotein antibody/ec [Endogenous Compound], Sm antibody/ec [Endogenous Compound], high disease activity status, adult, article, clinical feature, clinical outcome, comparative study, corticosteroid therapy, demography, disease activity, disease activity score, disease severity, female, human, major clinical study, male, middle aged, observational study, physician, priority journal, scoring system, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29232Test
Click here for full text options
LibKey Link -
2مورد إلكتروني
مصطلحات الفهرس: SLEDAI, social status, systemic lupus erythematosus/dt [Drug Therapy], autoantibody/ec [Endogenous Compound], azathioprine/dt [Drug Therapy], beta2 glycoprotein 1 antibody/ec [Endogenous Compound], cardiolipin antibody/ec [Endogenous Compound], corticosteroid/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], double stranded DNA antibody/ec [Endogenous Compound], hydroxychloroquine/dt [Drug Therapy], La antibody/ec [Endogenous Compound], leflunomide/dt [Drug Therapy], lupus anticoagulant/ec [Endogenous Compound], mercaptopurine/dt [Drug Therapy], methotrexate/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], neutrophil cytoplasmic antibody/ec [Endogenous Compound], phospholipid antibody/ec [Endogenous Compound], prednisolone/dt [Drug Therapy], rheumatoid factor/ec [Endogenous Compound], ribonucleoprotein antibody/ec [Endogenous Compound], Sm antibody/ec [Endogenous Compound], high disease activity status, adult, article, clinical feature, clinical outcome, comparative study, corticosteroid therapy, demography, disease activity, disease activity score, disease severity, female, human, major clinical study, male, middle aged, observational study, physician, priority journal, scoring system, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29232Test
Lupus Science and Medicine
LibKey Link -
3مورد إلكتروني
مصطلحات الفهرس: azathioprine/dt [Drug Therapy], biological product/dt [Drug Therapy], calcium channel blocking agent/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], iloprost/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], myeloblastin/ec [Endogenous Compound], myeloperoxidase/ec [Endogenous Compound], neutrophil cytoplasmic antibody/ec [Endogenous Compound], penicillamine/dt [Drug Therapy], phospholipid antibody/ec [Endogenous Compound], prednisolone/dt [Drug Therapy], rituximab/dt [Drug Therapy], scl 70 antibody/ec [Endogenous Compound], tocilizumab/dt [Drug Therapy], tumor necrosis factor inhibitor/dt [Drug Therapy], unclassified drug, vasodilator agent/dt [Drug Therapy], proteinase 3 antibody/ec [Endogenous Compound], myeloperoxidase antibody/ec [Endogenous Compound], adult, age, ANCA associated vasculitis/co [Complication], article, clinical feature, cohort analysis, comorbidity, disease association, female, human, interstitial lung disease/co [Complication], lung embolism/co [Complication], major clinical study, male, middle aged, mortality rate, prevalence, prognosis, prognostic assessment, sex, survival analysis, synovitis/co [Complication], systemic sclerosis/dt [Drug Therapy], abatacept/dt [Drug Therapy], autoantibody/ec [Endogenous Compound], Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35301Test
Arthritis Research and Therapy
Click here for full text options
LibKey Link -
4مورد إلكتروني
مصطلحات الفهرس: azathioprine/dt [Drug Therapy], biological product/dt [Drug Therapy], calcium channel blocking agent/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], iloprost/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], myeloblastin/ec [Endogenous Compound], myeloperoxidase/ec [Endogenous Compound], neutrophil cytoplasmic antibody/ec [Endogenous Compound], penicillamine/dt [Drug Therapy], phospholipid antibody/ec [Endogenous Compound], prednisolone/dt [Drug Therapy], rituximab/dt [Drug Therapy], scl 70 antibody/ec [Endogenous Compound], tocilizumab/dt [Drug Therapy], tumor necrosis factor inhibitor/dt [Drug Therapy], unclassified drug, vasodilator agent/dt [Drug Therapy], proteinase 3 antibody/ec [Endogenous Compound], myeloperoxidase antibody/ec [Endogenous Compound], adult, age, ANCA associated vasculitis/co [Complication], article, clinical feature, cohort analysis, comorbidity, disease association, female, human, interstitial lung disease/co [Complication], lung embolism/co [Complication], major clinical study, male, middle aged, mortality rate, prevalence, prognosis, prognostic assessment, sex, survival analysis, synovitis/co [Complication], systemic sclerosis/dt [Drug Therapy], abatacept/dt [Drug Therapy], autoantibody/ec [Endogenous Compound], Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35301Test
Arthritis Research and Therapy
LibKey Link -
5مورد إلكتروني
مصطلحات الفهرس: anticoagulation, antiinflammatory activity, antiphospholipid syndrome/et [Etiology], article, catabolism, cell surface, comparative study, complement deposition, controlled study, adenosine triphosphate/ec [Endogenous Compound], CD39 antigen/ec [Endogenous Compound], immunoglobulin G/ec [Endogenous Compound], interleukin 10/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], phospholipid antibody/ec [Endogenous Compound], purinergic receptor/ec [Endogenous Compound], thromboplastin/ec [Endogenous Compound], tumor necrosis factor/ec [Endogenous Compound], animal experiment, decidua, disease association, endothelium cell, enzyme activity, female, fetus, fetus resorption, human, immunohistochemistry, lipid peroxidation, male, mouse, nonhuman, oxidative stress, priority journal, reverse transcription polymerase chain reaction, RNA isolation, signal transduction, spontaneous abortion/et [Etiology], spontaneous abortion/pc [Prevention], 5' nucleotidase/ec [Endogenous Compound], adenosine/ec [Endogenous Compound], animal model, animal tissue, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/37276Test
Journal of Autoimmunity
Click here for full text options
LibKey Link -
6مورد إلكتروني
مصطلحات الفهرس: anticoagulation, antiinflammatory activity, antiphospholipid syndrome/et [Etiology], article, catabolism, cell surface, comparative study, complement deposition, controlled study, adenosine triphosphate/ec [Endogenous Compound], CD39 antigen/ec [Endogenous Compound], immunoglobulin G/ec [Endogenous Compound], interleukin 10/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], phospholipid antibody/ec [Endogenous Compound], purinergic receptor/ec [Endogenous Compound], thromboplastin/ec [Endogenous Compound], tumor necrosis factor/ec [Endogenous Compound], animal experiment, decidua, disease association, endothelium cell, enzyme activity, female, fetus, fetus resorption, human, immunohistochemistry, lipid peroxidation, male, mouse, nonhuman, oxidative stress, priority journal, reverse transcription polymerase chain reaction, RNA isolation, signal transduction, spontaneous abortion/et [Etiology], spontaneous abortion/pc [Prevention], 5' nucleotidase/ec [Endogenous Compound], adenosine/ec [Endogenous Compound], animal model, animal tissue, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/37276Test
Journal of Autoimmunity
Click here for full text options
LibKey Link -
7مورد إلكتروني
مصطلحات الفهرس: drug dose reduction, drug substitution, drug withdrawal, end stage renal disease/su [Surgery], end stage renal disease/th [Therapy], fever/co [Complication], gastroscopy, graft versus host reaction/dt [Drug Therapy], graft versus host reaction/pc [Prevention], Haemophilus parainfluenzae, hemolysis/di [Diagnosis], hemolysis/si [Side Effect], HLA matching, human, hypercholesterolemia, hypertension, hypotension/co [Complication], hypotension/dt [Drug Therapy], immunosuppressive treatment, intensive care, kidney biopsy, kidney cortex necrosis/di [Diagnosis], kidney pancreas transplantation, leg thrombosis/di [Diagnosis], leg thrombosis/dt [Drug Therapy], leukocyte count, low drug dose, male, medical history, middle aged, pancytopenia/si [Side Effect], paronychia/co [Complication], paronychia/dt [Drug Therapy], peritoneal dialysis, plasma exchange, Pseudomonas infection/co [Complication], Pseudomonas infection/dt [Drug Therapy], reflux esophagitis/di [Diagnosis], remission, review, sigmoidoscopy, thrombocyte count, thrombosis/dt [Drug Therapy], thrombosis/pc [Prevention], thrombosis prevention, thrombotic thrombocytopenic purpura/co [Complication], thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/dt [Drug Therapy], thrombotic thrombocytopenic purpura/th [Therapy], triacylglycerol lipase blood level, urinary tract infection/co [Complication], urinary tract infection/dt [Drug Therapy], vomiting/si [Side Effect], acetylsalicylic acid/dt [Drug Therapy], basiliximab/cb [Drug Combination], basiliximab/dt [Drug Therapy], beta2 glycoprotein 1/ec [Endogenous Compound], cardiolipin antibody/ec [Endogenous Compound], corticosteroid/cb [Drug Combination], corticosteroid/dt [Drug Therapy], creatinine/ec [Endogenous Compound], eculizumab/ae [Adverse Drug Reaction], eculizumab/dt [Drug Therapy], eculizumab/iv [Intravenous Drug Administration], enoxaparin/dt [Drug Therapy], everolimus/dt [Drug Therapy], flucloxacillin/dt [Drug Therapy], flucloxacillin/iv [Intravenous Drug Administration], HLA antibody/ec [Endogenous Compound], inotropic agent/dt [Drug Therapy], leukocyte antigen/ec [Endogenous Compound], mycophenolic acid/cb [Drug Combination], mycophenolic acid/dt [Drug Therapy], novel erythropoiesis stimulating protein/dt [Drug Therapy], phospholipid antibody/ec [Endogenous Compound], piperacillin plus tazobactam/dt [Drug Therapy], prednisolone/dt [Drug Therapy], tacrolimus/cb [Drug Combination], tacrolimus/dt [Drug Therapy], thymocyte antibody/dt [Drug Therapy], triacylglycerol lipase/ec [Endogenous Compound], warfarin/dt [Drug Therapy], catheter/am [Adverse Device Effect], human tissue, adult, anemia/di [Diagnosis], anemia/dt [Drug Therapy], antibody titer, bacterium identification, biochemical analysis, bone marrow biopsy, bone marrow suppression/di [Diagnosis], case report, catheter, creatinine blood level, deep vein thrombosis/di [Diagnosis], deep vein thrombosis/dt [Drug Therapy], diabetic retinopathy, diarrhea/co [Complication], diarrhea/si [Side Effect], Doppler flowmetry, drug dose increase, Review
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/39529Test
Nephrology
Click here for full text options
LibKey Link -
8مورد إلكتروني
مصطلحات الفهرس: drug dose reduction, drug substitution, drug withdrawal, end stage renal disease/su [Surgery], end stage renal disease/th [Therapy], fever/co [Complication], gastroscopy, graft versus host reaction/dt [Drug Therapy], graft versus host reaction/pc [Prevention], Haemophilus parainfluenzae, hemolysis/di [Diagnosis], hemolysis/si [Side Effect], HLA matching, human, hypercholesterolemia, hypertension, hypotension/co [Complication], hypotension/dt [Drug Therapy], immunosuppressive treatment, intensive care, kidney biopsy, kidney cortex necrosis/di [Diagnosis], kidney pancreas transplantation, leg thrombosis/di [Diagnosis], leg thrombosis/dt [Drug Therapy], leukocyte count, low drug dose, male, medical history, middle aged, pancytopenia/si [Side Effect], paronychia/co [Complication], paronychia/dt [Drug Therapy], peritoneal dialysis, plasma exchange, Pseudomonas infection/co [Complication], Pseudomonas infection/dt [Drug Therapy], reflux esophagitis/di [Diagnosis], remission, review, sigmoidoscopy, thrombocyte count, thrombosis/dt [Drug Therapy], thrombosis/pc [Prevention], thrombosis prevention, thrombotic thrombocytopenic purpura/co [Complication], thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/dt [Drug Therapy], thrombotic thrombocytopenic purpura/th [Therapy], triacylglycerol lipase blood level, urinary tract infection/co [Complication], urinary tract infection/dt [Drug Therapy], vomiting/si [Side Effect], acetylsalicylic acid/dt [Drug Therapy], basiliximab/cb [Drug Combination], basiliximab/dt [Drug Therapy], beta2 glycoprotein 1/ec [Endogenous Compound], cardiolipin antibody/ec [Endogenous Compound], corticosteroid/cb [Drug Combination], corticosteroid/dt [Drug Therapy], creatinine/ec [Endogenous Compound], eculizumab/ae [Adverse Drug Reaction], eculizumab/dt [Drug Therapy], eculizumab/iv [Intravenous Drug Administration], enoxaparin/dt [Drug Therapy], everolimus/dt [Drug Therapy], flucloxacillin/dt [Drug Therapy], flucloxacillin/iv [Intravenous Drug Administration], HLA antibody/ec [Endogenous Compound], inotropic agent/dt [Drug Therapy], leukocyte antigen/ec [Endogenous Compound], mycophenolic acid/cb [Drug Combination], mycophenolic acid/dt [Drug Therapy], novel erythropoiesis stimulating protein/dt [Drug Therapy], phospholipid antibody/ec [Endogenous Compound], piperacillin plus tazobactam/dt [Drug Therapy], prednisolone/dt [Drug Therapy], tacrolimus/cb [Drug Combination], tacrolimus/dt [Drug Therapy], thymocyte antibody/dt [Drug Therapy], triacylglycerol lipase/ec [Endogenous Compound], warfarin/dt [Drug Therapy], catheter/am [Adverse Device Effect], human tissue, adult, anemia/di [Diagnosis], anemia/dt [Drug Therapy], antibody titer, bacterium identification, biochemical analysis, bone marrow biopsy, bone marrow suppression/di [Diagnosis], case report, catheter, creatinine blood level, deep vein thrombosis/di [Diagnosis], deep vein thrombosis/dt [Drug Therapy], diabetic retinopathy, diarrhea/co [Complication], diarrhea/si [Side Effect], Doppler flowmetry, drug dose increase, Review
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/39529Test
Nephrology
Click here for full text options
LibKey Link -
9مورد إلكتروني
مصطلحات الفهرس: complement component C3/ec [Endogenous Compound], CD20 antibody/dt [Drug Therapy], calcineurin inhibitor/dt [Drug Therapy], azathioprine/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], serology, scoring system, polymyositis, practice guideline, prediction, adult, antibody detection, article, body mass, clinical feature, cohort analysis, complement deficiency, connective tissue disease, controlled study, demography, disease activity, disease association, disease severity, erythrocyte sedimentation rate, female, finger ulcer, gastrointestinal reflux/dt [Drug Therapy], human, major clinical study, male, abatacept/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], immunomodulating agent/dt [Drug Therapy], leflunomide/dt [Drug Therapy], methotrexate/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], penicillamine/dt [Drug Therapy], phospholipid antibody/ec [Endogenous Compound], prednisolone/dt [Drug Therapy], prednisolone/po [Oral Drug Administration], proton pump inhibitor/dt [Drug Therapy], ribonucleoprotein antibody/ec [Endogenous Compound], Ro antibody/ec [Endogenous Compound], Sm antibody/ec [Endogenous Compound], tocilizumab/dt [Drug Therapy], tumor necrosis factor inhibitor/dt [Drug Therapy], European Scleroderma Study Group disease activity score, prospective study, multicenter study (topic), patient information, complement component C4/ec [Endogenous Compound], rheumatology, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/39756Test
Arthritis Research and Therapy
Click here for full text options
LibKey Link -
10مورد إلكتروني
مصطلحات الفهرس: complement component C3/ec [Endogenous Compound], CD20 antibody/dt [Drug Therapy], calcineurin inhibitor/dt [Drug Therapy], azathioprine/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], serology, scoring system, polymyositis, practice guideline, prediction, adult, antibody detection, article, body mass, clinical feature, cohort analysis, complement deficiency, connective tissue disease, controlled study, demography, disease activity, disease association, disease severity, erythrocyte sedimentation rate, female, finger ulcer, gastrointestinal reflux/dt [Drug Therapy], human, major clinical study, male, abatacept/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], immunomodulating agent/dt [Drug Therapy], leflunomide/dt [Drug Therapy], methotrexate/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], penicillamine/dt [Drug Therapy], phospholipid antibody/ec [Endogenous Compound], prednisolone/dt [Drug Therapy], prednisolone/po [Oral Drug Administration], proton pump inhibitor/dt [Drug Therapy], ribonucleoprotein antibody/ec [Endogenous Compound], Ro antibody/ec [Endogenous Compound], Sm antibody/ec [Endogenous Compound], tocilizumab/dt [Drug Therapy], tumor necrosis factor inhibitor/dt [Drug Therapy], European Scleroderma Study Group disease activity score, prospective study, multicenter study (topic), patient information, complement component C4/ec [Endogenous Compound], rheumatology, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/39756Test
Arthritis Research and Therapy
LibKey Link